Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,063 | 35,937 | 57,019 | 20,202 | 30,171 |
| Marketable Securities | 32,068 | 39,078 | 110,953 | 173,655 | 107,051 |
| Receivables | 772 | 704 | 563 | 481 | N/A |
| Other current assets | 0 | 4,966 | 6,162 | 0 | 0 |
| TOTAL | $57,493 | $83,803 | $179,499 | $200,221 | $138,556 |
| Non-Current Assets | |||||
| PPE Net | 1,654 | 2,470 | 2,287 | 2,159 | 481 |
| Investments And Advances | 0 | 0 | 0 | 14,997 | 36,912 |
| Intangibles | 7,123 | 7,199 | 25,778 | 25,853 | 0 |
| Other Non-Current Assets | 4,514 | 4,825 | 68,002 | 279 | 136 |
| TOTAL | $13,291 | $14,494 | $96,067 | $43,288 | $37,529 |
| Total Assets | $70,784 | $98,297 | $275,566 | $243,509 | $176,085 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,254 | 9,917 | 11,675 | 7,822 | 2,845 |
| Accrued Expenses | 5,906 | 7,721 | 8,088 | 4,940 | 3,378 |
| TOTAL | $14,874 | $22,432 | $27,342 | $12,762 | $6,223 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,653 | N/A | 29,914 | N/A | N/A |
| Other Non-Current Liabilities | 7,240 | 5,404 | 2,637 | 4,936 | 372 |
| TOTAL | $18,260 | $5,953 | $33,100 | $5,485 | $372 |
| Total Liabilities | $33,134 | $28,385 | $60,442 | $18,247 | $6,595 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,804 | 41,529 | 41,270 | 30,901 | 26,089 |
| Retained earnings | -504,542 | -453,527 | -292,173 | -159,435 | -90,912 |
| Other shareholders' equity | -94 | -66 | -69 | -246 | -269 |
| TOTAL | $37,650 | $69,912 | $215,124 | $225,262 | $169,490 |
| Total Liabilities And Equity | $70,784 | $98,297 | $275,566 | $243,509 | $176,085 |